GSK PLC GSK StarRatingValueLabel_4Damien Conover, CFA - Sector Director - Morningstar Inc.

Latest Morningstar Commentary
DateAuthor Headline
30/04/2024James Gard Top FTSE 100 UK Dividend Paying Stocks
UPDATED for April 2024: No great surprises from earnings season, but AstraZeneca and HSBC have rewarded shareholders
19/02/2024Jocelyn Jovene Europe's Magnificent 7 Stocks Are Profitable - And Cheaper
Four years ago analysts at Goldman Sachs came up with the GRANOLAS acronym for Europe's leading stocks
05/02/2024Fernando Luque Growth & Tech Stocks Lead Gains at Start of Year
Our first markets barometer of the new year shows growth equities remain in favour after outperforming value through 2023
26/07/2023Alliance News Earnings Round-up: Lloyds, Rolls-Royce, GSK, BATS, Rio
A busy day for earnings provoked a range of share price movements 

Latest Company News

Damien Conover, CFA - Sector Director - Morningstar Inc.
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures